THREE International, in answer to the world’s current conversation and fascination with GLP-1 medications, has launched GLP THREE
, an injection-free, all-natural weight management solution. Formulated to reduce food cravings, support weight loss and maintain lean muscle mass, GLP THREE is delivered in an easy-to-take oral format and serves as an alternative to pharmaceutical approaches currently on the market.
“At the core of GLP THREE is MBC-267, a proprietary, all-natural peptide complex, derived from wild caught salmon in the heart of the Nordic Sea and mushrooms,” the company wrote in a statement. “The formulation is built around peptide science and plant-based compounds selected to support metabolic signaling pathways associated with appetite regulation and energy balance. Rather than introducing synthetic hormones, GLP THREE is designed to work in harmony with the body’s existing systems.”
GLP THREE expands THREE International’s product portfolio into the metabolic wellness space and simultaneously positions the company to be part of a broader movement, signaling its intent to remain competitive and relevant while staying true to its mission of supporting health and wellbeing through natural and holistic approaches.
“For THREE International, the launch represents not only a new product, but a forward-looking step into one of the most influential wellness conversations shaping the industry today,” the company stated.
The post THREE International Launches GLP THREE first appeared on Direct Selling News.
